Expressions of RASAL2, GATA6 and ASCL2 in Bladder Sarcomatoid Carcinoma and Their Relationships with Clinical Features and Prognosis

Expressions of RASAL2, GATA6 and ASCL2 in Bladder Sarcomatoid Carcinoma and Their Relationships with Clinical Features and Prognosis

ZHANG Li, ZHOU Li, JI Xingli, CUI Jiaqi, YANG Fan

PDF(1142 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1142 KB)

Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (3) : 438-442. DOI: 10.11748/bjmy.issn.1006-1703.2022.03.017

Clinical Investigation

Expressions of RASAL2, GATA6 and ASCL2 in Bladder Sarcomatoid Carcinoma and Their Relationships with Clinical Features and Prognosis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(3): 438-442 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.03.017

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1142 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉